CVS Health (CVS 1.63%) has taken its shareholders on a tumultuous ride over the past five years. While the stock is up around ...
Offers property and casualty insurance products, primarily underwriting single-family and condominium policies. Generates ...
Chip stocks have contributed to the Vanguard Information Technology ETF’s long-term outperformance. Three of the ETFs offer ...
This specialty insurer for automotive enthusiasts reported a notable insider sale amid strong year-over-year growth.
Semiconductor stocks have defied the broader weakness in the tech sector this year. While the tech-laden Nasdaq Composite ...
It's mostly financial stocks checking in over the next few days, but they're not alone. Several big tech and consumer names ...
On April 1, Eli Lilly (LLY 0.02%) and its shareholders received the news they were eagerly awaiting: the approval of the company's GLP-1 pill, Foundayo. While the company isn't th ...
DTCR offers targeted exposure to data center REITs and digital infrastructure firms through a rules-based, sector-focused ETF ...
Arm's new AGI CPU is designed for inferencing, and management expects strong demand. The company's total revenue could grow ...
This clinical-stage biotech focused on rare disease therapies reported a notable insider sale amid a year of sharp share ...
Tilray Brands (TLRY 2.44%) is a leading cannabis company based in Canada. However, despite leading the industry, intense ...
Berkshire Hathaway has sold well over half of its stake in Apple in recent years. Apple no longer accounts for half of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results